← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2015Last known activity
Dec 10, 2024
Timeline
1980s
- Jun 1, 1980
Hefei University— Founded
Drugs by trial phase (10 distinct, 9 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Colorectal Neoplasms
- Enteropathy-Associated T-Cell Lymphoma
- Glioma
- Immunoblastic Lymphadenopathy
- Leukemia
- Leukemia, Large Granular Lymphocytic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Prolymphocytic
- Leukemia, Prolymphocytic, B-Cell
- Leukemia, Prolymphocytic, T-Cell
- Lymphoma
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Pancreatic Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Stomach Neoplasms
Recent trials (10)
- NCT06740786CollaboratorN/ADec 10, 2024
- NCT06740786CollaboratorN/ADec 10, 2024
- NCT02819583CollaboratorPhase 1/Phase 2Oct 1, 2016
- NCT02944162CollaboratorPhase 1/Phase 2Oct 1, 2016
- NCT02892695CollaboratorPhase 1/Phase 2Sep 1, 2016
- NCT02839954CollaboratorPhase 1/Phase 2Jul 1, 2016
- NCT02742727CollaboratorPhase 1/Phase 2Mar 1, 2016
- NCT02748772Lead sponsorPhase 3Jan 1, 2016
- NCT02617134CollaboratorPhase 1/Phase 2Nov 1, 2015
- NCT02587689CollaboratorPhase 1/Phase 2Oct 1, 2015
Details
- Founded
- Hefei, CN Jun 1, 1980
- Last known activity
- Dec 10, 2024